Minimally Invasive Glaucoma Surgery.
Saved in:
: | |
---|---|
TeilnehmendeR: | |
Place / Publishing House: | Singapore : : Springer Singapore Pte. Limited,, 2020. ©2021. |
Year of Publication: | 2020 |
Edition: | 1st ed. |
Language: | English |
Online Access: | |
Physical Description: | 1 online resource (203 pages) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
5006384516 |
---|---|
ctrlnum |
(MiAaPQ)5006384516 (Au-PeEL)EBL6384516 (OCoLC)1243549940 |
collection |
bib_alma |
record_format |
marc |
spelling |
Sng, Chelvin C. A. Minimally Invasive Glaucoma Surgery. 1st ed. Singapore : Springer Singapore Pte. Limited, 2020. ©2021. 1 online resource (203 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Intro -- Foreword -- Contents -- About the Editors -- 1: Overview of MIGS -- 1.1 Trabecular Meshwork MIGS Devices and Techniques -- 1.2 Subconjunctival MIGS Devices -- 1.3 Suprachoroidal MIGS Devices -- 1.4 Cyclophotocoagulation (CPC) Procedures -- 1.5 Overview Summary -- References -- 2: Anatomy of the Aqueous Outflow Drainage Pathways -- 2.1 Introduction -- 2.2 Aqueous Humour Outflow -- 2.3 Trabecular Meshwork -- 2.4 Schlemm's Canal -- 2.5 Uveoscleral Outflow -- 2.6 Physiological Characteristics of Unconventional Outflow -- 2.7 Conjunctival Lymphatic System -- 2.8 Conclusions -- References -- 3: iStent: Trabecular Micro-Bypass Stent -- 3.1 Device Design -- 3.2 Patient Selection -- 3.3 Surgical Technique -- 3.3.1 Avoiding Complications and Surgical Pearls -- 3.3.2 Postoperative Management -- 3.4 Safety, Efficacy, and Clinical Results -- 3.4.1 iStent Trabecular Micro-Bypass Stent -- 3.4.2 iStent inject -- 3.5 Off-Label Use -- 3.6 Conclusion -- References -- 4: Ab-Interno Trabeculotomy -- 4.1 Introduction -- 4.2 Trabectome Device -- 4.3 Trabectome Procedure -- 4.4 Surgical Planning -- 4.4.1 Target IOP -- 4.4.2 Trabectome Can Be Performed in Patients with Narrow Angles -- 4.4.3 Contraindications -- 4.5 Results of Trabectome -- 4.5.1 Quality of Evidence -- 4.5.2 Clinical Efficacy -- 4.5.2.1 Trabectome-Alone -- 4.5.2.2 Trabectome-Alone Versus Trabeculectomy with Mitomycin C -- 4.5.2.3 Phaco-Trabectome Versus Trabectome-Alone -- 4.5.3 Phaco-Trabectome Versus Phaco-iStent -- 4.5.4 Preoperative Glaucoma Severity on Surgical Outcome -- 4.5.5 Other Potential Factors Affecting Efficacy -- 4.5.5.1 Does Prior Ineffective Selective Laser Trabeculoplasty (SLT) Alter Trabectome Outcomes? -- 4.5.5.2 Trabectome for Patients with Secondary Open-Angle Glaucoma. 4.5.5.3 Trabectome Can Be Performed in Patients with Previous Failed Trabeculectomy -- 4.5.5.4 Intraoperative Prognosticator for Postoperative Outcome -- 4.6 Complications of Trabectome -- 4.7 After Trabectome Has Failed -- 4.7.1 Does Trabectome Surgery Impact Future Glaucoma Surgery Outcomes? -- 4.7.2 Gonioscopy-Assisted Transluminal Trabeculotomy (GATT) Procedure as a Potential Treatment Option After Failed Trabectome Surgery -- 4.8 Conclusion -- References -- 5: Hydrus Microstent -- 5.1 Introduction -- 5.2 Material/Design -- 5.2.1 Mechanism of Action -- 5.3 Ex Vivo Testing -- 5.4 Surgical Technique -- 5.5 Site of Implantation -- 5.6 Patients -- 5.7 Efficacy -- 5.8 Safety -- 5.9 Conclusion -- References -- 6: XEN Gel Implant -- 6.1 Device Design and Evolution -- 6.2 Patient Selection -- 6.3 Surgical Technique -- 6.3.1 Avoiding Complications and Surgical Pearls -- 6.3.2 Postoperative Management -- 6.4 Safety, Efficacy, and Clinical Results -- 6.5 Off-Label Use -- 6.6 Conclusion -- References -- 7: PRESERFLO MicroShunt -- 7.1 Introduction -- 7.2 Device Design and Development -- 7.3 Development of SIBS -- 7.4 Clinical Data -- 7.5 Patient Selection -- 7.6 Surgical Technique -- 7.7 Complications -- 7.7.1 Intraoperative Complications -- 7.7.2 Early Postoperative Complications -- 7.7.3 Late Complications -- 7.8 Conclusion -- References -- 8: Suprachoroidal MIGS Devices -- 8.1 Introduction -- 8.2 Physiology of the Suprachoroidal Outflow Pathway -- 8.3 Early Surgical Approaches -- 8.4 Ab-Externo Suprachoroidal Devices -- 8.5 Ab-Interno Suprachoroidal MIGS Devices -- 8.5.1 CyPass Micro-Stent -- 8.5.1.1 Surgical Technique -- Poor Visualization of the Anterior Chamber Angle -- Resistance Encountered During Implantation -- Position of Device Too Anterior -- Position of Device Too Posterior. 8.5.1.2 Mechanism of Action -- 8.5.1.3 Efficacy -- 8.5.1.4 Complications -- Intra-operative Complications -- Post-operative Complications -- Inflammation -- Hypotony -- IOP Spikes -- Hyphaema -- Deterioration in Vision (Loss of ≥2 Lines of BCVA) -- Device Occlusion -- Device Malposition -- Additional Glaucoma Surgery -- Corneal Endothelial Cell Loss and Corneal Decompensation -- Cataract Progression -- 8.5.2 iStent Supra -- 8.5.2.1 Implantation Technique -- 8.5.2.2 Efficacy and Safety -- 8.5.3 MINIject -- 8.5.3.1 Implantation Technique -- 8.5.3.2 Efficacy and Safety -- References -- 9: New Modalities of Cycloablation and High-Intensity-Focused Ultrasound -- 9.1 Introduction -- 9.2 Transscleral Diode Cyclophotocoagulation (TSCPC) -- 9.2.1 Procedure -- 9.2.2 Indications -- 9.2.3 Results -- 9.2.4 Complications -- 9.3 Micropulse Transscleral Cyclophotocoagulation (MP-TSCPC) -- 9.3.1 Procedure -- 9.3.2 Indications -- 9.3.3 MP-TSCPC vs. TSCPC -- 9.3.4 Results -- 9.3.5 Complications -- 9.4 High-Intensity Focused Ultrasound (HIFU) -- 9.4.1 Procedure -- 9.4.2 Mechanism -- 9.4.3 Results -- 9.4.4 Complications -- 9.5 Conclusion -- References -- 10: Controversies in the Use of MIGS -- 10.1 Introduction -- 10.2 Phaco Alone Versus Phaco/MIGS, Is It Worth It? -- 10.3 Trabecular Meshwork and Canal-Based Procedures: Cut Versus Stent Versus Dilate -- 10.4 Endothelial Cell Loss and MIGS -- 10.5 Is the Suprachoroidal Space Dead? -- 10.6 The Great Debate: Subconjunctival MIGS and Trabeculectomy -- References -- 11: Globalization of MIGS -- 11.1 Introduction -- 11.2 Cost -- 11.3 Distribution Channels -- 11.4 Surgical Training -- 11.5 Patients -- 11.6 Regulatory Considerations and Other Concerns -- 11.7 Conclusion -- References -- Appendix A: iStent Trabecular Micro-Bypass Stent Implantation Narrative Instructions. Step 1: Patient Positioning and Setup -- Step 2: Adjusting Microscope and Identifying Landmarks -- Step 3: Accessing Anterior Chamber -- Step 4: Accessing Implantation Site -- Step 5: Stent Implantation (Left Eye Example) -- Step 6: Viscoelastic Removal -- Appendix B: iStent inject Implantation Narrative Instructions -- Step 1: Patient Positioning and Setup -- Step 2: Adjusting Microscope and Identifying Landmarks -- Step 3: Accessing Anterior Chamber -- Step 4: Accessing Implantation Site -- Step 5: Stent Implantation -- Step 6: Viscoelastic Removal -- Appendix C: iStent Supra Narrative Instructions -- Step 1: Patient Positioning and Setup -- Step 2: Adjusting Microscope and Identifying Landmarks -- Step 3: Accessing Anterior Chamber -- Step 4: Accessing Implantation Site -- Step 5: Stent Implantation -- Step 6: Viscoelastic Removal -- Appendix D: Trabectome -- Step 1: Clear Corneal Incision -- Step 2: Lower Anterior Chamber Intraocular Pressure to Visualize Schlemm's Canal -- Step 3: Microscope Tilt and Head -- Step 4: Goniolens Placement -- Step 5: Removal of Trabecular Meshwork -- Step 6: Irrigate, Aspirate, and Suture (With or Without Phaco) -- Appendix E: Hydrus Microstent Procedure Steps -- Step 1 -- Step 2 -- Step 3 -- Step 4 -- Step 5 -- Step 6 -- Step 7 -- Step 8 -- Step 9 -- Appendix F: XEN Gel Implant -- Appendix G: PRESERFLO MicroShunt Glaucoma Device Surgical Technique -- Preparation of PRESERFLO MicroShunt. Description based on publisher supplied metadata and other sources. Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. Electronic books. Barton, Keith. Print version: Sng, Chelvin C. A. Minimally Invasive Glaucoma Surgery Singapore : Springer Singapore Pte. Limited,c2020 9789811556319 ProQuest (Firm) https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=6384516 Click to View |
language |
English |
format |
eBook |
author |
Sng, Chelvin C. A. |
spellingShingle |
Sng, Chelvin C. A. Minimally Invasive Glaucoma Surgery. Intro -- Foreword -- Contents -- About the Editors -- 1: Overview of MIGS -- 1.1 Trabecular Meshwork MIGS Devices and Techniques -- 1.2 Subconjunctival MIGS Devices -- 1.3 Suprachoroidal MIGS Devices -- 1.4 Cyclophotocoagulation (CPC) Procedures -- 1.5 Overview Summary -- References -- 2: Anatomy of the Aqueous Outflow Drainage Pathways -- 2.1 Introduction -- 2.2 Aqueous Humour Outflow -- 2.3 Trabecular Meshwork -- 2.4 Schlemm's Canal -- 2.5 Uveoscleral Outflow -- 2.6 Physiological Characteristics of Unconventional Outflow -- 2.7 Conjunctival Lymphatic System -- 2.8 Conclusions -- References -- 3: iStent: Trabecular Micro-Bypass Stent -- 3.1 Device Design -- 3.2 Patient Selection -- 3.3 Surgical Technique -- 3.3.1 Avoiding Complications and Surgical Pearls -- 3.3.2 Postoperative Management -- 3.4 Safety, Efficacy, and Clinical Results -- 3.4.1 iStent Trabecular Micro-Bypass Stent -- 3.4.2 iStent inject -- 3.5 Off-Label Use -- 3.6 Conclusion -- References -- 4: Ab-Interno Trabeculotomy -- 4.1 Introduction -- 4.2 Trabectome Device -- 4.3 Trabectome Procedure -- 4.4 Surgical Planning -- 4.4.1 Target IOP -- 4.4.2 Trabectome Can Be Performed in Patients with Narrow Angles -- 4.4.3 Contraindications -- 4.5 Results of Trabectome -- 4.5.1 Quality of Evidence -- 4.5.2 Clinical Efficacy -- 4.5.2.1 Trabectome-Alone -- 4.5.2.2 Trabectome-Alone Versus Trabeculectomy with Mitomycin C -- 4.5.2.3 Phaco-Trabectome Versus Trabectome-Alone -- 4.5.3 Phaco-Trabectome Versus Phaco-iStent -- 4.5.4 Preoperative Glaucoma Severity on Surgical Outcome -- 4.5.5 Other Potential Factors Affecting Efficacy -- 4.5.5.1 Does Prior Ineffective Selective Laser Trabeculoplasty (SLT) Alter Trabectome Outcomes? -- 4.5.5.2 Trabectome for Patients with Secondary Open-Angle Glaucoma. 4.5.5.3 Trabectome Can Be Performed in Patients with Previous Failed Trabeculectomy -- 4.5.5.4 Intraoperative Prognosticator for Postoperative Outcome -- 4.6 Complications of Trabectome -- 4.7 After Trabectome Has Failed -- 4.7.1 Does Trabectome Surgery Impact Future Glaucoma Surgery Outcomes? -- 4.7.2 Gonioscopy-Assisted Transluminal Trabeculotomy (GATT) Procedure as a Potential Treatment Option After Failed Trabectome Surgery -- 4.8 Conclusion -- References -- 5: Hydrus Microstent -- 5.1 Introduction -- 5.2 Material/Design -- 5.2.1 Mechanism of Action -- 5.3 Ex Vivo Testing -- 5.4 Surgical Technique -- 5.5 Site of Implantation -- 5.6 Patients -- 5.7 Efficacy -- 5.8 Safety -- 5.9 Conclusion -- References -- 6: XEN Gel Implant -- 6.1 Device Design and Evolution -- 6.2 Patient Selection -- 6.3 Surgical Technique -- 6.3.1 Avoiding Complications and Surgical Pearls -- 6.3.2 Postoperative Management -- 6.4 Safety, Efficacy, and Clinical Results -- 6.5 Off-Label Use -- 6.6 Conclusion -- References -- 7: PRESERFLO MicroShunt -- 7.1 Introduction -- 7.2 Device Design and Development -- 7.3 Development of SIBS -- 7.4 Clinical Data -- 7.5 Patient Selection -- 7.6 Surgical Technique -- 7.7 Complications -- 7.7.1 Intraoperative Complications -- 7.7.2 Early Postoperative Complications -- 7.7.3 Late Complications -- 7.8 Conclusion -- References -- 8: Suprachoroidal MIGS Devices -- 8.1 Introduction -- 8.2 Physiology of the Suprachoroidal Outflow Pathway -- 8.3 Early Surgical Approaches -- 8.4 Ab-Externo Suprachoroidal Devices -- 8.5 Ab-Interno Suprachoroidal MIGS Devices -- 8.5.1 CyPass Micro-Stent -- 8.5.1.1 Surgical Technique -- Poor Visualization of the Anterior Chamber Angle -- Resistance Encountered During Implantation -- Position of Device Too Anterior -- Position of Device Too Posterior. 8.5.1.2 Mechanism of Action -- 8.5.1.3 Efficacy -- 8.5.1.4 Complications -- Intra-operative Complications -- Post-operative Complications -- Inflammation -- Hypotony -- IOP Spikes -- Hyphaema -- Deterioration in Vision (Loss of ≥2 Lines of BCVA) -- Device Occlusion -- Device Malposition -- Additional Glaucoma Surgery -- Corneal Endothelial Cell Loss and Corneal Decompensation -- Cataract Progression -- 8.5.2 iStent Supra -- 8.5.2.1 Implantation Technique -- 8.5.2.2 Efficacy and Safety -- 8.5.3 MINIject -- 8.5.3.1 Implantation Technique -- 8.5.3.2 Efficacy and Safety -- References -- 9: New Modalities of Cycloablation and High-Intensity-Focused Ultrasound -- 9.1 Introduction -- 9.2 Transscleral Diode Cyclophotocoagulation (TSCPC) -- 9.2.1 Procedure -- 9.2.2 Indications -- 9.2.3 Results -- 9.2.4 Complications -- 9.3 Micropulse Transscleral Cyclophotocoagulation (MP-TSCPC) -- 9.3.1 Procedure -- 9.3.2 Indications -- 9.3.3 MP-TSCPC vs. TSCPC -- 9.3.4 Results -- 9.3.5 Complications -- 9.4 High-Intensity Focused Ultrasound (HIFU) -- 9.4.1 Procedure -- 9.4.2 Mechanism -- 9.4.3 Results -- 9.4.4 Complications -- 9.5 Conclusion -- References -- 10: Controversies in the Use of MIGS -- 10.1 Introduction -- 10.2 Phaco Alone Versus Phaco/MIGS, Is It Worth It? -- 10.3 Trabecular Meshwork and Canal-Based Procedures: Cut Versus Stent Versus Dilate -- 10.4 Endothelial Cell Loss and MIGS -- 10.5 Is the Suprachoroidal Space Dead? -- 10.6 The Great Debate: Subconjunctival MIGS and Trabeculectomy -- References -- 11: Globalization of MIGS -- 11.1 Introduction -- 11.2 Cost -- 11.3 Distribution Channels -- 11.4 Surgical Training -- 11.5 Patients -- 11.6 Regulatory Considerations and Other Concerns -- 11.7 Conclusion -- References -- Appendix A: iStent Trabecular Micro-Bypass Stent Implantation Narrative Instructions. Step 1: Patient Positioning and Setup -- Step 2: Adjusting Microscope and Identifying Landmarks -- Step 3: Accessing Anterior Chamber -- Step 4: Accessing Implantation Site -- Step 5: Stent Implantation (Left Eye Example) -- Step 6: Viscoelastic Removal -- Appendix B: iStent inject Implantation Narrative Instructions -- Step 1: Patient Positioning and Setup -- Step 2: Adjusting Microscope and Identifying Landmarks -- Step 3: Accessing Anterior Chamber -- Step 4: Accessing Implantation Site -- Step 5: Stent Implantation -- Step 6: Viscoelastic Removal -- Appendix C: iStent Supra Narrative Instructions -- Step 1: Patient Positioning and Setup -- Step 2: Adjusting Microscope and Identifying Landmarks -- Step 3: Accessing Anterior Chamber -- Step 4: Accessing Implantation Site -- Step 5: Stent Implantation -- Step 6: Viscoelastic Removal -- Appendix D: Trabectome -- Step 1: Clear Corneal Incision -- Step 2: Lower Anterior Chamber Intraocular Pressure to Visualize Schlemm's Canal -- Step 3: Microscope Tilt and Head -- Step 4: Goniolens Placement -- Step 5: Removal of Trabecular Meshwork -- Step 6: Irrigate, Aspirate, and Suture (With or Without Phaco) -- Appendix E: Hydrus Microstent Procedure Steps -- Step 1 -- Step 2 -- Step 3 -- Step 4 -- Step 5 -- Step 6 -- Step 7 -- Step 8 -- Step 9 -- Appendix F: XEN Gel Implant -- Appendix G: PRESERFLO MicroShunt Glaucoma Device Surgical Technique -- Preparation of PRESERFLO MicroShunt. |
author_facet |
Sng, Chelvin C. A. Barton, Keith. |
author_variant |
c c a s cca ccas |
author2 |
Barton, Keith. |
author2_variant |
k b kb |
author2_role |
TeilnehmendeR |
author_sort |
Sng, Chelvin C. A. |
title |
Minimally Invasive Glaucoma Surgery. |
title_full |
Minimally Invasive Glaucoma Surgery. |
title_fullStr |
Minimally Invasive Glaucoma Surgery. |
title_full_unstemmed |
Minimally Invasive Glaucoma Surgery. |
title_auth |
Minimally Invasive Glaucoma Surgery. |
title_new |
Minimally Invasive Glaucoma Surgery. |
title_sort |
minimally invasive glaucoma surgery. |
publisher |
Springer Singapore Pte. Limited, |
publishDate |
2020 |
physical |
1 online resource (203 pages) |
edition |
1st ed. |
contents |
Intro -- Foreword -- Contents -- About the Editors -- 1: Overview of MIGS -- 1.1 Trabecular Meshwork MIGS Devices and Techniques -- 1.2 Subconjunctival MIGS Devices -- 1.3 Suprachoroidal MIGS Devices -- 1.4 Cyclophotocoagulation (CPC) Procedures -- 1.5 Overview Summary -- References -- 2: Anatomy of the Aqueous Outflow Drainage Pathways -- 2.1 Introduction -- 2.2 Aqueous Humour Outflow -- 2.3 Trabecular Meshwork -- 2.4 Schlemm's Canal -- 2.5 Uveoscleral Outflow -- 2.6 Physiological Characteristics of Unconventional Outflow -- 2.7 Conjunctival Lymphatic System -- 2.8 Conclusions -- References -- 3: iStent: Trabecular Micro-Bypass Stent -- 3.1 Device Design -- 3.2 Patient Selection -- 3.3 Surgical Technique -- 3.3.1 Avoiding Complications and Surgical Pearls -- 3.3.2 Postoperative Management -- 3.4 Safety, Efficacy, and Clinical Results -- 3.4.1 iStent Trabecular Micro-Bypass Stent -- 3.4.2 iStent inject -- 3.5 Off-Label Use -- 3.6 Conclusion -- References -- 4: Ab-Interno Trabeculotomy -- 4.1 Introduction -- 4.2 Trabectome Device -- 4.3 Trabectome Procedure -- 4.4 Surgical Planning -- 4.4.1 Target IOP -- 4.4.2 Trabectome Can Be Performed in Patients with Narrow Angles -- 4.4.3 Contraindications -- 4.5 Results of Trabectome -- 4.5.1 Quality of Evidence -- 4.5.2 Clinical Efficacy -- 4.5.2.1 Trabectome-Alone -- 4.5.2.2 Trabectome-Alone Versus Trabeculectomy with Mitomycin C -- 4.5.2.3 Phaco-Trabectome Versus Trabectome-Alone -- 4.5.3 Phaco-Trabectome Versus Phaco-iStent -- 4.5.4 Preoperative Glaucoma Severity on Surgical Outcome -- 4.5.5 Other Potential Factors Affecting Efficacy -- 4.5.5.1 Does Prior Ineffective Selective Laser Trabeculoplasty (SLT) Alter Trabectome Outcomes? -- 4.5.5.2 Trabectome for Patients with Secondary Open-Angle Glaucoma. 4.5.5.3 Trabectome Can Be Performed in Patients with Previous Failed Trabeculectomy -- 4.5.5.4 Intraoperative Prognosticator for Postoperative Outcome -- 4.6 Complications of Trabectome -- 4.7 After Trabectome Has Failed -- 4.7.1 Does Trabectome Surgery Impact Future Glaucoma Surgery Outcomes? -- 4.7.2 Gonioscopy-Assisted Transluminal Trabeculotomy (GATT) Procedure as a Potential Treatment Option After Failed Trabectome Surgery -- 4.8 Conclusion -- References -- 5: Hydrus Microstent -- 5.1 Introduction -- 5.2 Material/Design -- 5.2.1 Mechanism of Action -- 5.3 Ex Vivo Testing -- 5.4 Surgical Technique -- 5.5 Site of Implantation -- 5.6 Patients -- 5.7 Efficacy -- 5.8 Safety -- 5.9 Conclusion -- References -- 6: XEN Gel Implant -- 6.1 Device Design and Evolution -- 6.2 Patient Selection -- 6.3 Surgical Technique -- 6.3.1 Avoiding Complications and Surgical Pearls -- 6.3.2 Postoperative Management -- 6.4 Safety, Efficacy, and Clinical Results -- 6.5 Off-Label Use -- 6.6 Conclusion -- References -- 7: PRESERFLO MicroShunt -- 7.1 Introduction -- 7.2 Device Design and Development -- 7.3 Development of SIBS -- 7.4 Clinical Data -- 7.5 Patient Selection -- 7.6 Surgical Technique -- 7.7 Complications -- 7.7.1 Intraoperative Complications -- 7.7.2 Early Postoperative Complications -- 7.7.3 Late Complications -- 7.8 Conclusion -- References -- 8: Suprachoroidal MIGS Devices -- 8.1 Introduction -- 8.2 Physiology of the Suprachoroidal Outflow Pathway -- 8.3 Early Surgical Approaches -- 8.4 Ab-Externo Suprachoroidal Devices -- 8.5 Ab-Interno Suprachoroidal MIGS Devices -- 8.5.1 CyPass Micro-Stent -- 8.5.1.1 Surgical Technique -- Poor Visualization of the Anterior Chamber Angle -- Resistance Encountered During Implantation -- Position of Device Too Anterior -- Position of Device Too Posterior. 8.5.1.2 Mechanism of Action -- 8.5.1.3 Efficacy -- 8.5.1.4 Complications -- Intra-operative Complications -- Post-operative Complications -- Inflammation -- Hypotony -- IOP Spikes -- Hyphaema -- Deterioration in Vision (Loss of ≥2 Lines of BCVA) -- Device Occlusion -- Device Malposition -- Additional Glaucoma Surgery -- Corneal Endothelial Cell Loss and Corneal Decompensation -- Cataract Progression -- 8.5.2 iStent Supra -- 8.5.2.1 Implantation Technique -- 8.5.2.2 Efficacy and Safety -- 8.5.3 MINIject -- 8.5.3.1 Implantation Technique -- 8.5.3.2 Efficacy and Safety -- References -- 9: New Modalities of Cycloablation and High-Intensity-Focused Ultrasound -- 9.1 Introduction -- 9.2 Transscleral Diode Cyclophotocoagulation (TSCPC) -- 9.2.1 Procedure -- 9.2.2 Indications -- 9.2.3 Results -- 9.2.4 Complications -- 9.3 Micropulse Transscleral Cyclophotocoagulation (MP-TSCPC) -- 9.3.1 Procedure -- 9.3.2 Indications -- 9.3.3 MP-TSCPC vs. TSCPC -- 9.3.4 Results -- 9.3.5 Complications -- 9.4 High-Intensity Focused Ultrasound (HIFU) -- 9.4.1 Procedure -- 9.4.2 Mechanism -- 9.4.3 Results -- 9.4.4 Complications -- 9.5 Conclusion -- References -- 10: Controversies in the Use of MIGS -- 10.1 Introduction -- 10.2 Phaco Alone Versus Phaco/MIGS, Is It Worth It? -- 10.3 Trabecular Meshwork and Canal-Based Procedures: Cut Versus Stent Versus Dilate -- 10.4 Endothelial Cell Loss and MIGS -- 10.5 Is the Suprachoroidal Space Dead? -- 10.6 The Great Debate: Subconjunctival MIGS and Trabeculectomy -- References -- 11: Globalization of MIGS -- 11.1 Introduction -- 11.2 Cost -- 11.3 Distribution Channels -- 11.4 Surgical Training -- 11.5 Patients -- 11.6 Regulatory Considerations and Other Concerns -- 11.7 Conclusion -- References -- Appendix A: iStent Trabecular Micro-Bypass Stent Implantation Narrative Instructions. Step 1: Patient Positioning and Setup -- Step 2: Adjusting Microscope and Identifying Landmarks -- Step 3: Accessing Anterior Chamber -- Step 4: Accessing Implantation Site -- Step 5: Stent Implantation (Left Eye Example) -- Step 6: Viscoelastic Removal -- Appendix B: iStent inject Implantation Narrative Instructions -- Step 1: Patient Positioning and Setup -- Step 2: Adjusting Microscope and Identifying Landmarks -- Step 3: Accessing Anterior Chamber -- Step 4: Accessing Implantation Site -- Step 5: Stent Implantation -- Step 6: Viscoelastic Removal -- Appendix C: iStent Supra Narrative Instructions -- Step 1: Patient Positioning and Setup -- Step 2: Adjusting Microscope and Identifying Landmarks -- Step 3: Accessing Anterior Chamber -- Step 4: Accessing Implantation Site -- Step 5: Stent Implantation -- Step 6: Viscoelastic Removal -- Appendix D: Trabectome -- Step 1: Clear Corneal Incision -- Step 2: Lower Anterior Chamber Intraocular Pressure to Visualize Schlemm's Canal -- Step 3: Microscope Tilt and Head -- Step 4: Goniolens Placement -- Step 5: Removal of Trabecular Meshwork -- Step 6: Irrigate, Aspirate, and Suture (With or Without Phaco) -- Appendix E: Hydrus Microstent Procedure Steps -- Step 1 -- Step 2 -- Step 3 -- Step 4 -- Step 5 -- Step 6 -- Step 7 -- Step 8 -- Step 9 -- Appendix F: XEN Gel Implant -- Appendix G: PRESERFLO MicroShunt Glaucoma Device Surgical Technique -- Preparation of PRESERFLO MicroShunt. |
isbn |
9789811556326 9789811556319 |
callnumber-first |
R - Medicine |
callnumber-subject |
RE - Ophthalmology |
callnumber-label |
RE1-994 |
callnumber-sort |
RE 11 3994 |
genre |
Electronic books. |
genre_facet |
Electronic books. |
url |
https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=6384516 |
illustrated |
Not Illustrated |
oclc_num |
1243549940 |
work_keys_str_mv |
AT sngchelvinca minimallyinvasiveglaucomasurgery AT bartonkeith minimallyinvasiveglaucomasurgery |
status_str |
n |
ids_txt_mv |
(MiAaPQ)5006384516 (Au-PeEL)EBL6384516 (OCoLC)1243549940 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Minimally Invasive Glaucoma Surgery. |
author2_original_writing_str_mv |
noLinkedField |
marc_error |
Info : MARC8 translation shorter than ISO-8859-1, choosing MARC8. --- [ 856 : z ] |
_version_ |
1792331057186471936 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>08859nam a22004213i 4500</leader><controlfield tag="001">5006384516</controlfield><controlfield tag="003">MiAaPQ</controlfield><controlfield tag="005">20240229073836.0</controlfield><controlfield tag="006">m o d | </controlfield><controlfield tag="007">cr cnu||||||||</controlfield><controlfield tag="008">240229s2020 xx o ||||0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9789811556326</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9789811556319</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(MiAaPQ)5006384516</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(Au-PeEL)EBL6384516</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1243549940</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">MiAaPQ</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="e">pn</subfield><subfield code="c">MiAaPQ</subfield><subfield code="d">MiAaPQ</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RE1-994</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Sng, Chelvin C. A.</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Minimally Invasive Glaucoma Surgery.</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1st ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Singapore :</subfield><subfield code="b">Springer Singapore Pte. Limited,</subfield><subfield code="c">2020.</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©2021.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (203 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Intro -- Foreword -- Contents -- About the Editors -- 1: Overview of MIGS -- 1.1 Trabecular Meshwork MIGS Devices and Techniques -- 1.2 Subconjunctival MIGS Devices -- 1.3 Suprachoroidal MIGS Devices -- 1.4 Cyclophotocoagulation (CPC) Procedures -- 1.5 Overview Summary -- References -- 2: Anatomy of the Aqueous Outflow Drainage Pathways -- 2.1 Introduction -- 2.2 Aqueous Humour Outflow -- 2.3 Trabecular Meshwork -- 2.4 Schlemm's Canal -- 2.5 Uveoscleral Outflow -- 2.6 Physiological Characteristics of Unconventional Outflow -- 2.7 Conjunctival Lymphatic System -- 2.8 Conclusions -- References -- 3: iStent: Trabecular Micro-Bypass Stent -- 3.1 Device Design -- 3.2 Patient Selection -- 3.3 Surgical Technique -- 3.3.1 Avoiding Complications and Surgical Pearls -- 3.3.2 Postoperative Management -- 3.4 Safety, Efficacy, and Clinical Results -- 3.4.1 iStent Trabecular Micro-Bypass Stent -- 3.4.2 iStent inject -- 3.5 Off-Label Use -- 3.6 Conclusion -- References -- 4: Ab-Interno Trabeculotomy -- 4.1 Introduction -- 4.2 Trabectome Device -- 4.3 Trabectome Procedure -- 4.4 Surgical Planning -- 4.4.1 Target IOP -- 4.4.2 Trabectome Can Be Performed in Patients with Narrow Angles -- 4.4.3 Contraindications -- 4.5 Results of Trabectome -- 4.5.1 Quality of Evidence -- 4.5.2 Clinical Efficacy -- 4.5.2.1 Trabectome-Alone -- 4.5.2.2 Trabectome-Alone Versus Trabeculectomy with Mitomycin C -- 4.5.2.3 Phaco-Trabectome Versus Trabectome-Alone -- 4.5.3 Phaco-Trabectome Versus Phaco-iStent -- 4.5.4 Preoperative Glaucoma Severity on Surgical Outcome -- 4.5.5 Other Potential Factors Affecting Efficacy -- 4.5.5.1 Does Prior Ineffective Selective Laser Trabeculoplasty (SLT) Alter Trabectome Outcomes? -- 4.5.5.2 Trabectome for Patients with Secondary Open-Angle Glaucoma.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">4.5.5.3 Trabectome Can Be Performed in Patients with Previous Failed Trabeculectomy -- 4.5.5.4 Intraoperative Prognosticator for Postoperative Outcome -- 4.6 Complications of Trabectome -- 4.7 After Trabectome Has Failed -- 4.7.1 Does Trabectome Surgery Impact Future Glaucoma Surgery Outcomes? -- 4.7.2 Gonioscopy-Assisted Transluminal Trabeculotomy (GATT) Procedure as a Potential Treatment Option After Failed Trabectome Surgery -- 4.8 Conclusion -- References -- 5: Hydrus Microstent -- 5.1 Introduction -- 5.2 Material/Design -- 5.2.1 Mechanism of Action -- 5.3 Ex Vivo Testing -- 5.4 Surgical Technique -- 5.5 Site of Implantation -- 5.6 Patients -- 5.7 Efficacy -- 5.8 Safety -- 5.9 Conclusion -- References -- 6: XEN Gel Implant -- 6.1 Device Design and Evolution -- 6.2 Patient Selection -- 6.3 Surgical Technique -- 6.3.1 Avoiding Complications and Surgical Pearls -- 6.3.2 Postoperative Management -- 6.4 Safety, Efficacy, and Clinical Results -- 6.5 Off-Label Use -- 6.6 Conclusion -- References -- 7: PRESERFLO MicroShunt -- 7.1 Introduction -- 7.2 Device Design and Development -- 7.3 Development of SIBS -- 7.4 Clinical Data -- 7.5 Patient Selection -- 7.6 Surgical Technique -- 7.7 Complications -- 7.7.1 Intraoperative Complications -- 7.7.2 Early Postoperative Complications -- 7.7.3 Late Complications -- 7.8 Conclusion -- References -- 8: Suprachoroidal MIGS Devices -- 8.1 Introduction -- 8.2 Physiology of the Suprachoroidal Outflow Pathway -- 8.3 Early Surgical Approaches -- 8.4 Ab-Externo Suprachoroidal Devices -- 8.5 Ab-Interno Suprachoroidal MIGS Devices -- 8.5.1 CyPass Micro-Stent -- 8.5.1.1 Surgical Technique -- Poor Visualization of the Anterior Chamber Angle -- Resistance Encountered During Implantation -- Position of Device Too Anterior -- Position of Device Too Posterior.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">8.5.1.2 Mechanism of Action -- 8.5.1.3 Efficacy -- 8.5.1.4 Complications -- Intra-operative Complications -- Post-operative Complications -- Inflammation -- Hypotony -- IOP Spikes -- Hyphaema -- Deterioration in Vision (Loss of ≥2 Lines of BCVA) -- Device Occlusion -- Device Malposition -- Additional Glaucoma Surgery -- Corneal Endothelial Cell Loss and Corneal Decompensation -- Cataract Progression -- 8.5.2 iStent Supra -- 8.5.2.1 Implantation Technique -- 8.5.2.2 Efficacy and Safety -- 8.5.3 MINIject -- 8.5.3.1 Implantation Technique -- 8.5.3.2 Efficacy and Safety -- References -- 9: New Modalities of Cycloablation and High-Intensity-Focused Ultrasound -- 9.1 Introduction -- 9.2 Transscleral Diode Cyclophotocoagulation (TSCPC) -- 9.2.1 Procedure -- 9.2.2 Indications -- 9.2.3 Results -- 9.2.4 Complications -- 9.3 Micropulse Transscleral Cyclophotocoagulation (MP-TSCPC) -- 9.3.1 Procedure -- 9.3.2 Indications -- 9.3.3 MP-TSCPC vs. TSCPC -- 9.3.4 Results -- 9.3.5 Complications -- 9.4 High-Intensity Focused Ultrasound (HIFU) -- 9.4.1 Procedure -- 9.4.2 Mechanism -- 9.4.3 Results -- 9.4.4 Complications -- 9.5 Conclusion -- References -- 10: Controversies in the Use of MIGS -- 10.1 Introduction -- 10.2 Phaco Alone Versus Phaco/MIGS, Is It Worth It? -- 10.3 Trabecular Meshwork and Canal-Based Procedures: Cut Versus Stent Versus Dilate -- 10.4 Endothelial Cell Loss and MIGS -- 10.5 Is the Suprachoroidal Space Dead? -- 10.6 The Great Debate: Subconjunctival MIGS and Trabeculectomy -- References -- 11: Globalization of MIGS -- 11.1 Introduction -- 11.2 Cost -- 11.3 Distribution Channels -- 11.4 Surgical Training -- 11.5 Patients -- 11.6 Regulatory Considerations and Other Concerns -- 11.7 Conclusion -- References -- Appendix A: iStent Trabecular Micro-Bypass Stent Implantation Narrative Instructions.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Step 1: Patient Positioning and Setup -- Step 2: Adjusting Microscope and Identifying Landmarks -- Step 3: Accessing Anterior Chamber -- Step 4: Accessing Implantation Site -- Step 5: Stent Implantation (Left Eye Example) -- Step 6: Viscoelastic Removal -- Appendix B: iStent inject Implantation Narrative Instructions -- Step 1: Patient Positioning and Setup -- Step 2: Adjusting Microscope and Identifying Landmarks -- Step 3: Accessing Anterior Chamber -- Step 4: Accessing Implantation Site -- Step 5: Stent Implantation -- Step 6: Viscoelastic Removal -- Appendix C: iStent Supra Narrative Instructions -- Step 1: Patient Positioning and Setup -- Step 2: Adjusting Microscope and Identifying Landmarks -- Step 3: Accessing Anterior Chamber -- Step 4: Accessing Implantation Site -- Step 5: Stent Implantation -- Step 6: Viscoelastic Removal -- Appendix D: Trabectome -- Step 1: Clear Corneal Incision -- Step 2: Lower Anterior Chamber Intraocular Pressure to Visualize Schlemm's Canal -- Step 3: Microscope Tilt and Head -- Step 4: Goniolens Placement -- Step 5: Removal of Trabecular Meshwork -- Step 6: Irrigate, Aspirate, and Suture (With or Without Phaco) -- Appendix E: Hydrus Microstent Procedure Steps -- Step 1 -- Step 2 -- Step 3 -- Step 4 -- Step 5 -- Step 6 -- Step 7 -- Step 8 -- Step 9 -- Appendix F: XEN Gel Implant -- Appendix G: PRESERFLO MicroShunt Glaucoma Device Surgical Technique -- Preparation of PRESERFLO MicroShunt.</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="590" ind1=" " ind2=" "><subfield code="a">Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. </subfield></datafield><datafield tag="655" ind1=" " ind2="4"><subfield code="a">Electronic books.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Barton, Keith.</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="a">Sng, Chelvin C. A.</subfield><subfield code="t">Minimally Invasive Glaucoma Surgery</subfield><subfield code="d">Singapore : Springer Singapore Pte. Limited,c2020</subfield><subfield code="z">9789811556319</subfield></datafield><datafield tag="797" ind1="2" ind2=" "><subfield code="a">ProQuest (Firm)</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=6384516</subfield><subfield code="z">Click to View</subfield></datafield></record></collection> |